Foghorn Therapeutics Inc. announced that on January 16, 2024, the Board of Directors of Foghorn Therapeutics Inc. appointed Stephen J. DiPalma as Treasurer and interim Chief Financial Officer, effective January 16, 2024. The Company is continuing its search for a permanent CFO. Mr. DiPalma, age 65, has served as a managing director at Danforth, a consultancy firm specializing in working with life sciences companies, since April 2014.

Prior to and during his tenure at Danforth, Mr. DiPalma has served as chief financial officer to a number of public and privately held companies. Mr. DiPalma received a B.S. in finance and management information systems from the University of Massachusetts-Lowell and an M.B.A. from Babson College. Mr. DiPalma has no family relationships with any of the executive officers or directors of the Company.

Other than as described herein, there are no arrangements or understandings between Mr. DiPalma and any other person pursuant to which he was appointed as an officer of the Company.